Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB25FWTBT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,362
Award facts
- Contract value 100% obligated
- $38,362.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Dupixent 300 mg/2 ml syringes with a ceiling value of $38,362.04 and a firm fixed price structure. This is a non-set-aside, competitively awarded contract with an ultimate completion date of September 29, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis and other inflammatory conditions, representing a specialized pharmaceutical product within the company's extensive federal medical supply portfolio.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare systems. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal contracting relationship with the Defense Logistics Agency and serves critical medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's track record demonstrates consistent success in competing for federal medical supply contracts across a diverse range of pharmaceutical products and therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FWTBT?
SPE2DB25FWTBT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FWTBT worth?
The government has obligated $38,362 on SPE2DB25FWTBT.
Is contract SPE2DB25FWTBT an order under another contract?
Yes. SPE2DB25FWTBT is a delivery order under SPE2DB25D3007, an indefinite delivery contract.
Was contract SPE2DB25FWTBT competed?
The extent of competition for SPE2DB25FWTBT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award